187 related articles for article (PubMed ID: 8923858)
1. Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma.
Sasano H; Frost AR; Saitoh R; Harada N; Poutanen M; Vihko R; Bulun SE; Silverberg SG; Nagura H
J Clin Endocrinol Metab; 1996 Nov; 81(11):4042-6. PubMed ID: 8923858
[TBL] [Abstract][Full Text] [Related]
2. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
3. 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters.
Suzuki T; Moriya T; Ariga N; Kaneko C; Kanazawa M; Sasano H
Br J Cancer; 2000 Feb; 82(3):518-23. PubMed ID: 10682658
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years.
Honma N; Takubo K; Sawabe M; Arai T; Akiyama F; Sakamoto G; Utsumi T; Yoshimura N; Harada N
J Clin Endocrinol Metab; 2006 Feb; 91(2):607-13. PubMed ID: 16303840
[TBL] [Abstract][Full Text] [Related]
5. Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study.
Song D; Liu G; Luu-The V; Zhao D; Wang L; Zhang H; Xueling G; Li S; Désy L; Labrie F; Pelletier G
J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):136-44. PubMed ID: 16930994
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
Takagi M; Miki Y; Miyashita M; Hata S; Yoda T; Hirakawa H; Sagara Y; Rai Y; Ohi Y; Tamaki K; Ishida T; Suzuki T; Ouchi N; Sasano H
Breast Cancer Res Treat; 2016 Feb; 156(1):45-55. PubMed ID: 26943913
[TBL] [Abstract][Full Text] [Related]
9. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
10. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
11. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
12. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
Suzuki T; Darnel AD; Akahira JI; Ariga N; Ogawa S; Kaneko C; Takeyama J; Moriya T; Sasano H
J Clin Endocrinol Metab; 2001 May; 86(5):2250-7. PubMed ID: 11344235
[TBL] [Abstract][Full Text] [Related]
13. Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.
Chanplakorn N; Chanplakorn P; Suzuki T; Ono K; Chan MS; Miki Y; Saji S; Ueno T; Toi M; Sasano H
Breast Cancer Res Treat; 2010 Apr; 120(3):639-48. PubMed ID: 20151319
[TBL] [Abstract][Full Text] [Related]
14. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
15. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders.
Sasano H; Nagura H; Harada N; Goukon Y; Kimura M
Hum Pathol; 1994 May; 25(5):530-5. PubMed ID: 8200649
[TBL] [Abstract][Full Text] [Related]
17. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study.
Sasano H; Kimura M; Shizawa S; Kimura N; Nagura H
J Clin Endocrinol Metab; 1996 Aug; 81(8):3063-7. PubMed ID: 8768875
[TBL] [Abstract][Full Text] [Related]
18. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
[TBL] [Abstract][Full Text] [Related]
20. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]